Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Nordimet
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nordimet 20mg/0.8ml solution for injection pre-filled pens
0801030P0BFAFFS
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 3,207 |
|
Nordimet 15mg/0.6ml solution for injection pre-filled pens
0801030P0BFADFQ
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 2,491 |
|
Nordimet 25mg/1ml solution for injection pre-filled pens
0801030P0BFAHFU
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 1,773 |
|
Nordimet 10mg/0.4ml solution for injection pre-filled pens
0801030P0BFABFN
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 993 |
|
Nordimet 12.5mg/0.5ml solution for injection pre-filled pens
0801030P0BFACFP
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 576 |
|
Nordimet 17.5mg/0.7ml solution for injection pre-filled pens
0801030P0BFAEFR
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 546 |
|
Nordimet 22.5mg/0.9ml solution for injection pre-filled pens
0801030P0BFAGFT
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 369 |
|
Nordimet 7.5mg/0.3ml solution for injection pre-filled pens
0801030P0BFAAFM
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 295 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.